UltraTech, JK Lakshmi Among Axis Securities’ Top Picks Amid Positive Cement Outlook For Q3— Check Target Price

Cement Q3 Preview: Axis Securities remains positive on UltraTech Cement, JK Lakshmi Cement as structural plays on India’s infrastructure growth.

Axis Securities Sees Strong cement demand in Q3 FY26; UltraTech, Dalmia Bharat among top picks.

(Photo source: Envato)

Axis Securities projects cement demand to grow 7–8% in FY26, supported by infrastructure push and housing activity. Price recovery and margin improvement are expected in Q4 FY26 as peak season begins.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Axis Securities Report

Axis Securities remains positive on the dynamics of the cement industry based on the following factors:

Demand Momentum

With demand projected to rise 6–8% CAGR over the next two years, fueled by infrastructure, housing, and commercial real estate, strong government spending through FY26–FY27 will further support volume growth.

Capacity Expansion

With large capex planned by FY27-28 and 100+ mtpa of new grinding capacity, India’s cement industry is set for a major expansion, boosting capacity and supply chain efficiency.

Margin support

Industry consolidation, cost efficiencies, and operational improvements are set to boost margins over the medium term, even with seasonal fluctuations.

Policy tailwinds

Lower GST, increased infrastructure spending, and a revival in realty and rural housing create a favourable backdrop for long-term profits.

Top Picks:

Axis Securities remains positive on UltraTech Cement, Dalmia Bharat, and JK Lakshmi Cement as structural plays on India’s infrastructure growth (

Click on the attachment to read the full report:

Axis Securities Cement Q3FY26-Earnings-Preview.pdf
Read Document

Also Read: Laurus Labs, Biocon, Rubicon Lead Motilal Oswal’s Top Picks As Q3 Healthcare Outlook Brightens — Check Details

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google